Chenchen Ma

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Emergency Department

Molecular Docking

Replacement Therapy

Top Venues

Current medicinal chemistry

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Chenchen Ma, Siyuan Cui, Ruirong Xu
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment. Current medicinal chemistry 31 (29) (2024)
Chenchen Ma, Siyuan Cui, Ruirong Xu
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment. Current medicinal chemistry (2024)
Chenchen Ma, Siyuan Cui, Ruirong Xu
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment. Current medicinal chemistry 31 (29) (2024)
Chenchen Ma, Peng Liu, Siyuan Cui, Chang Gao, Xing Tan, Zhao-Peng Liu, Rui-Rong Xu
The Identification of APOBEC3G as a Potential Prognostic Biomarker in Acute Myeloid Leukemia and a Possible Drug Target for Crotonoside. Molecules (Basel, Switzerland) 27 (18) (2022)